American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead: Association of Cannabis Use With Cardiovascular Outcomes Among US Adults

Lead: Association of Cannabis Use With Cardiovascular Outcomes Among US Adults

Tuesday 12th March 2024

Explore how daily cannabis use may impact cardiovascular health and other key addiction medicine topics in this episode of 'This Week in Addiction Medicine'.
6 minutes
Informative
Educational
Eye-opening
Supportive
Honest

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Cannabis and Heart Health: Unveiling the Risks

Episode Overview

  • Daily cannabis use may increase the risk of heart attack and stroke.
  • Children of parents with alcohol use disorder face higher risks for psychiatric and substance use disorders.
  • Emergency departments face barriers in providing take-home buprenorphine.
  • Recovery Community Centres are rapidly growing and offering diverse support services.
  • Benzodiazepines can be safe and effective when prescribed correctly.
Daily cannabis use is associated with an increased risk of myocardial infarction and stroke.
Ever wondered how cannabis use might affect your heart? This episode of 'This Week in Addiction Medicine from ASAM' dives into the potential cardiovascular risks associated with daily cannabis use. The lead story, sourced from the Journal of the American Heart Association, highlights a study that found daily cannabis users have an increased risk of myocardial infarction and stroke. Interestingly, the risks were even higher among adults who had never smoked cigarettes.
If you're curious about the broader implications of cannabis on heart health, this episode offers some eye-opening data. But that's not all. The episode also covers a range of studies tackling different aspects of addiction medicine. One study from the American Journal of Psychiatry explores the heightened risk of psychiatric and substance use disorders in children of parents with alcohol use disorder.
Another study discusses the barriers emergency department healthcare workers face when providing take-home buprenorphine, a medication for opioid use disorder. You'll also hear about the rapid growth of Recovery Community Centres (RCCs) across the United States, as detailed in a survey from the Journal of Addiction Medicine. These centres offer a variety of support services, including naloxone training and employment assistance, and are becoming increasingly open to Medication for Opioid Use Disorder (MOUD).
Other notable mentions include long-term outcomes of buprenorphine treatment for opioid use disorder and the nuanced discussion around the safety and efficacy of benzodiazepines. The episode wraps up with insights into why patients prefer staying in low-threshold buprenorphine programs rather than transitioning to clinic-based care. This episode is packed with valuable information for anyone interested in addiction medicine. Whether you're a healthcare professional or someone affected by addiction, you'll find something worth listening to here.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.